NX Pharmagen
Louisville · Founded 2010
About NX Pharmagen
NX PharmaGen’s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company’s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.2M
- Last round: Debt Financing (Oct 2022)
- Website: http://www.nxpharmagen.com
- Phone: +1 8887887249
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/nx-pharmagen-7926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.